Prognostic values of tumor endothelial markers in patients with colorectal cancer

被引:56
|
作者
Rmali, K. A. [1 ]
Puntis, M. C. A. [1 ]
Jiang, W. G. [1 ]
机构
[1] Univ Cardiff, Wales Coll Med, Univ Dept Surg, Metastasis & Angiogenesis Res Grp, Cardiff CF14 4XN, Wales
关键词
Colon cancer; Angiogenesis; Tumor endothelial markers; Dukes stages;
D O I
10.3748/wjg.v11.i9.1283
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: Tumor endothelial markers (TEMs) are a newly discovered family of endothelial markers associated with tumor specific angiogenesis. This study sought to examine the levels of expression (qualitatively and quantitatively) for TEMs in human colon cancer. METHODS: Human colorectal cancer tissues (n = 48) and normal background tissues (n = 31) were obtained after surgery. RNA was extracted from frozen sections for gene amplification. The expression of TEMs (TEM-1 to TEM-8) was assessed using RT-PCR and their transcript levels were determined using real-time-quantitative PCR (Q-RT-PCR). RESULTS: TEM-1 (P = 0.01), TEM-7 (P = 0.04), TEM-7R (P = 0.03), TEM-8 (P = 0.001) significantly raised in colon cancer tissues compared with the levels detected in normal background tissues. The expressions of TEM-2 and TEM-6 were found to be not significantly different between tumor tissues and normal tissues (P > 0.05). Patients who had cancer penetrating into and through the muscularis propria of the bowel wall and developed nodal involvement (Dukes C) exhibited significantly higher levels of TEM -8 compared to patients who were node negative (P < 0.05). TEM-7 and TEM-7R showed high level of transcripts in Dukes C, but they were not statistically significant. CONCLUSION: The level of the expression of TEM-1, TEM-7, TEM-7R and TEM-8 (but not TEM-2 and TEM-6) were associated with both nodal involvement and disease progression, and may therefore, have a prognostic value in colorectal cancer. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:1283 / 1286
页数:4
相关论文
共 50 条
  • [21] Predictive and prognostic markers in colorectal cancer
    Turkington, Richard C.
    Coyle, Vkky M.
    Johnston, Patrick G.
    Eatock, Martin M.
    PERSONALIZED MEDICINE, 2007, 4 (03) : 295 - 306
  • [22] Genetic prognostic markers in colorectal cancer
    Houlston, RS
    Tomlinson, IPM
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1997, 50 (06): : 281 - 288
  • [23] Predictive and Prognostic Markers in Colorectal Cancer
    Ben George
    Scott Kopetz
    Current Oncology Reports, 2011, 13 : 206 - 215
  • [24] Genetic prognostic markers for colorectal cancer
    Offit, K
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (02): : 124 - 125
  • [25] Molecular prognostic markers in colorectal cancer
    Ivanov, Krasimir
    Kolev, Nikola
    Tonev, Anton
    Tontchev, Anton
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Prognostic and Predictive Markers in Colorectal Cancer
    Reddy, Sangeetha
    Vergo, Maxwell
    Benson, Al B., III
    CURRENT COLORECTAL CANCER REPORTS, 2011, 7 (04) : 267 - 274
  • [27] Biomarkers Discovery for Colorectal Cancer: A Review on Tumor Endothelial Markers as Perspective Candidates
    Pietrzyk, Lukasz
    DISEASE MARKERS, 2016, 2016
  • [28] Prognostic prediction model of colorectal cancer based on preoperative serum tumor markers
    Diao, Yu-Hang
    Rao, Si-Qi
    Shu, Xin-Peng
    Cheng, Yong
    Tan, Can
    Wang, Li-Juan
    Peng, Dong
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (05):
  • [29] Expression of Endoglin and Vascular Endothelial Growth Factor as Prognostic Markers in Experimental Colorectal Cancer
    Ilhan, Nevin
    Gungor, Hilal
    Gul, H. Fatih
    Eroksuz, Hatice
    ANTICANCER RESEARCH, 2016, 36 (08) : 3953 - 3959
  • [30] The prognostic value of tumor markers in patients with resectable gastric cancer
    Slagter, A.
    Vollebergh, M.
    Caspers, I.
    van Sandick, J.
    Sikorska, K.
    Lind, P.
    Nordsmark, M.
    Putter, H.
    Braak, J.
    Kranenbarg, E. Meershoek-Klein
    van de Velde, C.
    Jansen, E.
    Cats, A.
    van Laarhoven, H.
    van Grieken, N.
    Verheij, M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S306 - S307